Gliosarcoma: distinct molecular pathways and genomic alterations identified by DNA copy number/SNP microarray...

Area of Science:

• Neuro-oncology
• Genomics
• Molecular Biology

Background:

• Gliosarcoma is a rare and aggressive histologic variant of glioblastoma (GBM).
• It carries a poor prognosis with median survival under one year.
• Standard treatments include surgery, radiation, and chemotherapy, but no cure exists.

Purpose of the Study:

• To comprehensively analyze DNA copy number (CN) alterations in gliosarcoma.
• To identify molecular pathways associated with these CN changes.
• To explore potential therapeutic targets for gliosarcoma.

Main Methods:

• Cytogenomic DNA copy number (CN) microarray (OncoScan®) was performed on 18 gliosarcoma cases.
• MetaCore™ enrichment analysis was used to identify associated molecular pathways.

Main Results:

• Copy number loss was the most frequent alteration (57%), significantly exceeding amplifications and loss of heterozygosity.
• Chromosomes 9 and 10 showed the highest number of losses, often involving CDKN2A/B.
• Copy number gains (26.2%) were most common on chromosome 7, with pathways like HOXA, Rho GTPases, and EGFR implicated.

Conclusions:

• Detected copy number alterations and pathways may be key drivers of gliosarcoma oncogenesis.
• Findings provide a foundation for targeted molecular analysis and potential therapeutic strategies.
• Further research into these genomic alterations could lead to novel treatments for gliosarcoma.